• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Putative biorientation of chromosomes in cell division protein 1-like 2 (BOD1P)

ACP15042

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP15042 Target NameBOD1L2
Target SynonymsBOD1L2; BOD1P; FAM44CBiorientation of chromosomes in cell division protein 1-like 2; Biorientation of chromosomes in cell division protein 1 pseudogene; Protein FAM44CFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-172
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8IYS8
Background Information
  • Uniprot Id

    Q8IYS8

  • Target Species

    Human

  • Target Name

    BOD1L2

  • Target Full Name

    Biorientation of chromosomes in cell division protein 1-like 2

  • Target Function

    May play a role in proper chromosome biorientation through the detection or correction of syntelic attachments in mitotic spindles.

  • Target Subcellular Location

    Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Chromosome, centromere, kinetochore.

  • Target Protein Families

    BOD1 family

  • Target Synonyms

    BOD1L2; BOD1P; FAM44CBiorientation of chromosomes in cell division protein 1-like 2; Biorientation of chromosomes in cell division protein 1 pseudogene; Protein FAM44C

Inquire Recombinant Human Putative biorientation of chromosomes in cell division protein 1-like 2 (BOD1P) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification